Home / Indicators / Oncology novel active substance (NAS) launches (annual) vs Oncology novel active substance (NAS) launches (cumulative) Oncology novel active substance (NAS) launches (annual) vs Oncology novel active substance (NAS) launches (cumulative) In 2020, oncology novel active substance (NAS) launches (annual) worldwide stood at 26, against 132 for oncology novel active substance (NAS) launches (cumulative).
Change the pair
Compare different indicators
The series
Over time Global, spaced by time. Both series are in count,
so they share one axis; the legend names each line.
Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 6 observations
2 series · one axis Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative): Global Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative). 2 indicators on one axis: Oncology novel active substance (NAS) launches (annual), Oncology novel active substance (NAS) launches (cumulative). 6 observations from 2005–2024 to 2024, ranging from 16 to 282. Latest values: Oncology novel active substance (NAS) launches (annual) 25 (2024); Oncology novel active substance (NAS) launches (cumulative) 132 (2020–2024).
0
100
200
300
2005
2008
2011
2014
2017
2020
2023
25
132
Oncology novel active substance (NAS) launches (annual)
Oncology novel active substance (NAS) launches (cumulative)
Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative): Global Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative). 2 indicators on one axis: Oncology novel active substance (NAS) launches (annual), Oncology novel active substance (NAS) launches (cumulative). 6 observations from 2005–2024 to 2024, ranging from 16 to 282. Latest values: Oncology novel active substance (NAS) launches (annual) 25 (2024); Oncology novel active substance (NAS) launches (cumulative) 132 (2020–2024).
0
100
200
300
2005
2008
2011
2014
2017
2020
2023
25
132
Oncology novel active substance (NAS) launches (annual)
Oncology novel active substance (NAS) launches (cumulative)
Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative): Global Oncology novel active substance (NAS) launches (annual) and Oncology novel active substance (NAS) launches (cumulative). 2 indicators on one axis: Oncology novel active substance (NAS) launches (annual), Oncology novel active substance (NAS) launches (cumulative). 6 observations from 2005–2024 to 2024, ranging from 16 to 282. Latest values: Oncology novel active substance (NAS) launches (annual) 25 (2024); Oncology novel active substance (NAS) launches (cumulative) 132 (2020–2024).
0
100
200
300
2005
2008
2011
2014
2017
2020
2023
25
132
Oncology novel active substance (NAS) launches (annual)
Oncology novel active substance (NAS) launches (cumulative)
View the underlying data Shared periods
Side by side Only 2 periods are
published for both series. Comparing
anything else would mean comparing different years.
Provenance
Where these numbers come from Annual number of oncology novel active substances launched, for a single year or averaged across years.
3 observations in Global · source
organisations: IQVIA
Total number of oncology novel active substances launched over a stated multi-year period.
3 observations in Global · source
organisations: IQVIA
Data published under CC BY 4.0 .
Series A as JSON · Series B as JSON